CDC walks back more COVID vaccine guidance
“vaccination status is no longer used to inform source control, screening testing, or post-exposure recommendations.”
In a Sept. 23 update to its COVID guidance, the Centers for Disease Control and Prevention (CDC) altered its definition of vaccine status, essentially acknowledging that one’s vaccination status has little to do with the transmission of the virus.
The update states “vaccination status is no longer used to inform source control, screening testing, or post-exposure recommendations.”
The updates also “clarified” that “screening testing of asymptomatic healthcare personnel, including those in nursing homes, is at the discretion of the healthcare facility.”
Here is the full list of updates issued on Sept. 23.
Included in the latest updates is the CDC is also dropping masks in nursing homes and hospitals, with the qualifier that those institutions or facilities are not in areas seeing high levels of COVID-19 transmission.
The CDC is still relying on and recommending that the public and localities use its flawed Community Transmission metric.
"Community transmission is the metric currently recommended to guide select practices in healthcare settings to allow for earlier intervention, before there is strain on the healthcare system and to better protect the individuals seeking care in these settings," the CDC said in the update.
While masking in healthcare settings was loosened, the CDC tightened.
Specifically, the CDC had previously said people who had a past COVID-19 infection didn't need to test for the virus if exposed within 90 days of that previous infection. The update last week says testing "should be considered for those who have recovered in the prior 31-90 days."
Research, such as a recent study out of France, is beginning to mount showing people can have multiple reinfections with variants (such as Omicron and its subvariants) in a short period of time.
Checking in on vaccinations and Myocarditis
The jump in myocarditis cases among young people has become increasingly more noticeable since the shots were made available to those 18 and under and, perhaps coincidentally, the recent updates made by the CDC follow the publication of its own study of 519 heart inflammation cases in 12-29 year-olds following mRNA vaccination.
That study, published on Sept. 21 in The Lancet Child & Adolescent Health, showed that after 90 days that 1 in 6 individuals still had not "fully recovered" after the onset of myocarditis and that around 1 in 100 of those cases hadn't improved at all.
“Cardiac assessment of patients diagnosed with myocarditis after mRNA COVID-19 vaccination often shows increased cardiac biomarkers (eg, troponin concentrations) and atypical cardiac imaging (eg, echocardiograms), which are similar findings to those shown for viral or acute myocarditis,” the study says.
Yet the study amazingly concludes that even though there seems to be a higher risk for Myocarditis after an mRNA COVID shot, “the benefits of mRNA COVID-19 vaccines have been shown to outweigh the risk of myocarditis.”
The study cites the CDC’s own data from the Vaccine Adverse Events Reporting System (VAERS) from Jan. 12 to Nov. 5, 2021, which logged some 989 myocarditis reports for persons aged 12-29.
A quick breakdown of what the study found related to the 989 cases:
836 (85%) patients were at least 90 days post-myocarditis onset.
Between Aug 24, 2021, and Jan 12, 2022, 519 (62%) of the 836 eligible patients were contacted and had data collected on them.
Of the 836 patients, 204 (24%) patients had no telephone number available for contact and of the remaining 375 patients, 357 (95%) patients consented to the survey and 18 (5%) patients declined.
Of the 519, 126 patients were collected by patient survey only, 162 patients were via health-care provider survey only, and 231 patients were via both the patient and health-care provider survey, 257 (31%) patients were unreachable.
The median age of the 393 individuals whose healthcare providers completed a survey was 17 and the vast majority was male. Specifically, the study states that “Median patient age was 17 years (IQR 15–22); 457 (88%) patients were male and 61 (12%) were female.”
But it’s not just the young and healthy being affected, as one of Britain’s top cardiologists found out in a very personal way - his healthy and fit 73-year-old father died suddenly in July of 2021.
The post-mortem revealed two severe blockages in the coronary arteries, which caused his father’s death. Malhotra had examined his father’s heart months prior to death and determined he was in excellent health.
Malhotra then went on a journey delving into mRNA vaccines, adverse reactions, and deaths, but also identifying the root causes of public health failures like forced vaccine passports and mandates.
The result was a two-part paper looking at those topics and a call for a “global pause” of the use of mRNA COVID-19 vaccines.
The paper’s first part looked at the harms and benefits of the COVID-19 mRNA vaccines including adverse reactions and deaths following vaccination. The main focus of the paper was the Pfizer mRNA vaccine.
“Re-analysis of randomised controlled trials using the messenger ribonucleic acid (mRNA) technology suggests a greater risk of serious adverse events from the vaccines than being hospitalised from COVID-19,” the results portion of the first part of the paper reads.
Part two of Malhotra’s paper concentrated on those in authority (government, medical, etc.) that “have supported unethical, coercive, and misinformed policies such as vaccine mandates and vaccine passports, undermining the principles of ethical evidence-based medical practice and informed consent.”
The conclusion Malhotra reached in paper two is that all vaccinations for COVID need to stop and the medical community needs to rehabilitate the public’s trust in them.
The paper was published in the Journal of Insulin Resistance following peer review. View part one and part two.